CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigms

European Journal of Immunology

Volumn 41, Issue 5, 2011, Pages 1298-1308

  Scalzo Inguanti, Karen ^a   Plebanski, Magdalena ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

CD4 T cells; Cell surface molecules; Cellular activation

Indexed keywords

ANTIBODY; CD38 ANTIGEN; CD45RA ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7 RECEPTOR; L SELECTIN; RECOMBINANT INTERLEUKIN 7; STAT5 PROTEIN; TUMOR NECROSIS FACTOR;

ANTIGEN BINDING; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TH2 CELL; UPREGULATION;

ANTIGENS, CD38; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; L-SELECTIN; LYMPHOCYTE ACTIVATION; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CCR7; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955166318     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040726     Document Type: Article

References (47)

1. Ma, A., Koka, R. and Burkett, P., Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 2006. 24: 657-679.
2. Geginat, J., Sallusto, F. and Lanzavecchia, A., Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J. Exp. Med. 2001. 194: 1711-1719.
3. Fry, T. J. and Mackall, C. L., Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol. 2001. 22: 564-571.
4. Fry, T. J. and Mackall, C. L., The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 2005. 174: 6571-6576.
5. Park, J. H., Yu, Q., Erman, B., Appelbaum, J. S., Montoya-Durango, D., Grimes, H. L. and Singer, A., Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004. 21: 289-302.
6. Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D. and Ahmed, R., Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 2003. 4: 1191-1198.
7. Schluns, K. S., Kieper, W. C., Jameson, S. C. and Lefrancois, L., Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 2000. 1: 426-432.
8. Lenz, D. C., Kurz, S. K., Lemmens, E., Schoenberger, S. P., Sprent, J., Oldstone, M. B. and Homann, D., IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. Proc. Natl. Acad. Sci. USA 2004. 101: 9357-9362.
9. Akbar, A. N., Terry, L., Timms, A., Beverley, P. C. and Janossy, G., Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J. Immunol. 1988. 140: 2171-2178.
10. Merkenschlager, M., Terry, L., Edwards, R. and Beverley, P. C., Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation. Eur. J. Immunol. 1988. 18: 1653-1661.
11. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
12. Howard, M., Grimaldi, J. C., Bazan, J. F., Lund, F. E., Santos-Argumedo, L., Parkhouse, R. M., Walseth, T. F. and Lee, H. C., Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 1993. 262: 1056-1059.
13. Ibrahim, S., Jilani, I., O'Brien, S., Rogers, A., Manshouri, T., Giles, F., Faderl, S. et al., Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Cancer 2003. 97: 1914-1919.
14. Deaglio, S., Morra, M., Mallone, R., Ausiello, C. M., Prager, E., Garbarino, G., Dianzani, U. et al., Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. 1998. 160: 395-402.
15. Mehta, K., Shahid, U. and Malavasi, F., Human CD38, a cell-surface protein with multiple functions. FASEB J. 1996. 10: 1408-1417.
16. Dianzani, U., Funaro, A., DiFranco, D., Garbarino, G., Bragardo, M., Redoglia, V., Buonfiglio, D. et al., Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J. Immunol. 1994. 153: 952-959.
17. Picker, L. J., Treer, J. R., Ferguson-Darnell, B., Collins, P. A., Buck, D. and Terstappen, L. W., Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J. Immunol. 1993. 150: 1105-1121.
18. Forster, R., Davalos-Misslitz, A. C. and Rot, A., CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 2008. 8: 362-371.
19. Salmi, M. and Jalkanen, S., Cell-surface enzymes in control of leukocyte trafficking. Nat. Rev. Immunol. 2005. 5: 760-771.
20. Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T. and Aydin, S., Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 2008. 88: 841-886.
21. Guse, A. H., Biochemistry, biology, and pharmacology of cyclic adenosine diphosphoribose (cADPR). Curr. Med. Chem. 2004. 11: 847-855.
22. Deaglio, S., Dianzani, U., Horenstein, A. L., Fernandez, J. E., van Kooten, C., Bragardo, M., Funaro, A. et al., Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells. J. Immunol. 1996. 156: 727-734.
23. Hassan, J. and Reen, D. J., IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur. J. Immunol. 1998. 28: 3057-3065.
24. von Freeden-Jeffry, U., Solvason, N., Howard, M. and Murray, R., The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997. 7: 147-154.
25. Bhan, A. K., Reinherz, E. L., Poppema, S., McCluskey, R. T. and Schlossman, S. F., Location of T cell and major histocompatibility complex antigens in the human thymus. J. Exp. Med. 1980. 152: 771-782.
26. Sandoval-Montes, C. and Santos-Argumedo, L., CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines. J. Leukoc. Biol. 2005. 77: 513-521.
27. Kestens, L., Vanham, G., Vereecken, C., Vandenbruaene, M., Vercauteren, G., Colebunders, R. L. and Gigase, P. L., Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection. Clin. Exp. Immunol. 1994. 95: 436-441.
28. Malavasi, F., Funaro, A., Alessio, M., DeMonte, L. B., Ausiello, C. M., Dianzani, U., Lanza, F. et al., CD38: a multi-lineage cell activation molecule with a split personality. Int. J. Clin. Lab Res. 1992. 22: 73-80.
29. Reinis, M., Morra, M., Funaro, A., Di Primio, R. and Malavasi, F., Functional associations of CD38 with CD3 on the T-cell membrane. J. Biol. Regul. Homeost. Agents 1997. 11: 137-142.
30. Morra, M., Zubiaur, M., Terhorst, C., Sancho, J. and Malavasi, F., CD38 is functionally dependent on the TCR/CD3 complex in human T cells. FASEB J. 1998. 12: 581-592.
31. Tan, J. T., Dudl, E., LeRoy, E., Murray, R., Sprent, J., Weinberg, K. I. and Surh, C. D., IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 2001. 98: 8732-8737.
32. Kondrack, R. M., Harbertson, J., Tan, J. T., McBreen, M. E., Surh, C. D. and Bradley, L. M., Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 2003. 198: 1797-1806.
33. Azevedo, R. I., Soares, M. V., Barata, J. T., Tendeiro, R., Serra-Caetano, A., Victorino, R. M. and Sousa, A. E., IL-7 sustains CD31 expression in human naive CD4+ T cells and preferentially expands the CD31+ subset in a PI3K-dependent manner. Blood 2009. 113: 2999-3007.
34. Kimmig, S., Przybylski, G. K., Schmidt, C. A., Laurisch, K., Mowes, B., Radbruch, A. and Thiel, A., Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 2002. 195: 789-794.
35. Demeure, C. E., Byun, D. G., Yang, L. P., Vezzio, N. and Delespesse, G., CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells. Immunology 1996. 88: 110-115.
36. Okumura, M., Fujii, Y., Inada, K., Nakahara, K. and Matsuda, H., Both CD45RA+ and CD45RA- subpopulations of CD8+ T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J. Immunol. 1993. 150: 429-437.
37. Suarez, A., Mozo, L. and Gutierrez, C., Generation of CD4(+)CD45RA(+) effector T cells by stimulation in the presence of cyclic adenosine 5'-monophosphate-elevating agents. J. Immunol. 2002. 169: 1159-1167.
38. Richards, D., Chapman, M. D., Sasama, J., Lee, T. H. and Kemeny, D. M., Immune memory in CD4+ CD45RA+ T cells. Immunology 1997. 91: 331-339.
39. Wynn, T. A., IL-13 effector functions. Annu. Rev. Immunol. 2003. 21: 425-456.
40. Pene, J., Rousset, F., Briere, F., Chretien, I., Bonnefoy, J. Y., Spits, H., Yokota, T. et al., IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl. Acad. Sci. USA 1988. 85: 6880-6884.
41. Erb, K. J. and Le Gros, G., The role of Th2 type CD4+ T cells and Th2 type CD8+ T cells in asthma. Immunol. Cell Biol. 1996. 74: 206-208.
42. Mattes, J., Yang, M., Siqueira, A., Clark, K., MacKenzie, J., McKenzie, A. N., Webb, D. C. et al., IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J. Immunol. 2001. 167: 1683-1692.
43. Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y. and Elias, J. A., Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 1999. 103: 779-788.
44. Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski, G., de Waal Malefyt, R. and de Vries, J. E., Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 1993. 90: 3730-3734.
45. Marone, G., Florio, G., Triggiani, M., Petraroli, A. and de Paulis, A., Mechanisms of IgE elevation in HIV-1 infection. Crit. Rev. Immunol. 2000. 20: 477-496.
46. Savarino, A., Bensi, T., Chiocchetti, A., Bottarel, F., Mesturini, R., Ferrero, E., Calosso, L. et al., Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120. FASEB J. 2003. 17: 461-463.
47. Chun, T. W., Justement, J. S., Sanford, C., Hallahan, C. W., Planta, M. A., Loutfy, M., Kottilil, S. et al., Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. Proc. Natl. Acad. Sci. USA 2004. 101: 2464-2469.